Published in Infect Immun on December 01, 1974
Antibacterial activity of cationic proteins from human granulocytes. J Clin Invest (1975) 2.97
Lysis and killing of bacteria by lysosomal proteinases. Infect Immun (1976) 1.50
Reactive oxygen species regulate neutrophil recruitment and survival in pneumococcal pneumonia. Am J Respir Crit Care Med (2008) 1.33
NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury. Front Immunol (2013) 1.04
Carbonic anhydrase is essential for Streptococcus pneumoniae growth in environmental ambient air. J Bacteriol (2010) 0.97
Effect of extracellular serum in the stimulation of intracellular killing of streptococci by human monocytes. Infect Immun (1980) 0.94
Extracellular stimulation by serum proteins required for maximal intracellular killing of microorganisms by mouse peritoneal macrophages. Infect Immun (1984) 0.91
Anaerobic phagocytosis, killing, and degradation of Streptococcus pneumoniae by human peripheral blood leukocytes. Infect Immun (1985) 0.88
Free-radical reaction in biological systems. Ann R Coll Surg Engl (1980) 0.80
Leucocyte superoxide dismutase in rheumatoid arthritis. Ann Rheum Dis (1983) 0.78
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
Interactions between rabbit polymorphonuclear leucocytes and staphylococci. J Exp Med (1959) 17.17
Iodination of bacteria: a bactericidal mechanism. J Exp Med (1967) 10.30
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26
Degranulation of polymorphonuclear leucocytes following phagocytosis of microorganisms. J Exp Med (1960) 10.03
Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest (1969) 7.61
Quantitative analysis of phospholipids by thin-layer chromatography. Biochem J (1964) 6.13
The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med (1969) 4.96
Arginine-rich proteins of polymorphonuclear leukocyte lysosomes. Antimicrobial specificity and biochemical heterogeneity. J Exp Med (1968) 4.49
Leukocyte oxidase: defective activity in chronic granulomatous disease. Science (1967) 4.25
Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet (1966) 3.97
The arrangement of proteins in the human erythrocyte membrane. Biochem Biophys Res Commun (1970) 3.54
Temporal changes in pH within the phagocytic vacuole of the polymorphonuclear neutrophilic leukocyte. J Cell Biol (1973) 3.34
Simultaneous production of two capsular polysaccharides by pneumococcus. I. Properties of a pneumococcus manifesting binary capsulation. J Exp Med (1959) 3.30
Evidence that peroxidation of lysosomal membranes is initiated by hydroxyl free radicals produced during flavin enzyme activity. J Biol Chem (1973) 2.99
Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood. N Engl J Med (1969) 2.92
Respiration and glucose oxidation in human and guinea pig leukocytes: comparative studies. J Clin Invest (1970) 2.83
The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters. Arch Biochem Biophys (1962) 2.65
Lipid composition and permeability of liposomes. Biochim Biophys Acta (1968) 2.59
Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. J Clin Invest (1970) 2.04
Improvement of leukocyte bactericidal activity in chronic granulomatous disease. Blood (1970) 1.90
Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles. J Clin Invest (1972) 1.84
Composition of phospholipids and of phospholipid fatty acids and aldehydes in human red cells. J Lipid Res (1967) 1.74
The detection of oxidation in liposome preparations. Biochim Biophys Acta (1970) 1.70
Fat metabolism in higher plants. XII. alpha-Oxidation of long chain fatty acids. J Biol Chem (1959) 1.68
Stages in the incorporation of fatty acids into red blood cells. J Clin Invest (1968) 1.49
Phospholipid metabolism by phagocytic cells. VI. Observations on the fate of phospholipids of granulocytes and ingested Escherichia coli during phagocytosis. Biochim Biophys Acta (1972) 1.22
ACID LIPASE AND PHOSPHOLIPASE ACTIVITY IN HOMOGENATES OF RABBIT POLYMORPHONUCLEAR LEUKOCYTES. Am J Physiol (1963) 1.22
The role of the phagocyte in host-parasite interactions. 23. Relation of bactericidal activity to peroxidase-associated decarboxylation and deamination. Biochem Biophys Res Commun (1970) 1.21
Role of peroxide in phagocytic killing of pneumococci. Infect Immun (1974) 1.15
Lipid peroxidation during enzymatic iodination of rat liver endoplasmic reticulum. Biochem Biophys Res Commun (1972) 1.09
Laboratory models of chronic granulomatous disease. J Reticuloendothel Soc (1972) 1.03
Changes in fatty acid metabolism in human leukemic granulocytes during phagocytosis. J Lab Clin Med (1970) 0.88
Essential fatty acids and glucose permeability of lecithin membranes. Biochim Biophys Acta (1971) 0.83
The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest (1975) 7.40
Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med (1968) 6.91
Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location. Nature (1986) 6.34
Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A (1987) 5.65
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med (1999) 5.05
Leukocyte oxidase: defective activity in chronic granulomatous disease. Science (1967) 4.25
Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann Intern Med (2001) 3.80
Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci U S A (1981) 3.73
Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem (1988) 3.34
Molecular cloning of protein 4.1, a major structural element of the human erythrocyte membrane skeleton. Proc Natl Acad Sci U S A (1986) 3.22
An experimental study of acute neonatal enterocolitis--the importance of breast milk. J Pediatr Surg (1974) 3.21
Degranulation of leukocytes in chronic granulomatous disease. J Clin Invest (1969) 3.17
Hemagglutination typing of Escherichia coli: definition of seven hemagglutination types. J Clin Microbiol (1980) 3.03
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest (1983) 2.91
Respiration and glucose oxidation in human and guinea pig leukocytes: comparative studies. J Clin Invest (1970) 2.83
The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood (1976) 2.76
Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous disease. Science (1968) 2.56
Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (1999) 2.51
Deficiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections. N Engl J Med (1982) 2.47
Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mo1 deficiency. Effects of cell activation on Mo1/LFA-1 surface expression in normal and deficient leukocytes. J Clin Invest (1984) 2.46
The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40
Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues. J Exp Med (1985) 2.37
Disorders of phagocytic cell function. Prog Hematol (1971) 2.37
Deficiency of a surface membrane glycoprotein (Mo1) in man. J Clin Invest (1984) 2.29
Analysis of factors regulating erythrocyte deformability. J Clin Invest (1980) 2.29
Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates. Proc Natl Acad Sci U S A (1987) 2.27
Deficiency of skeletal membrane protein band 4.1 in homozygous hereditary elliptocytosis. Implications for erythrocyte membrane stability. J Clin Invest (1981) 2.27
A congenital haemolytic anaemia with thermal sensitivity of the erythrocyte membrane. Br J Haematol (1975) 2.15
Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. J Clin Invest (1969) 2.11
Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood (1977) 2.10
Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun (1988) 2.06
Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. J Clin Invest (1970) 2.04
Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J Pediatr (1996) 2.02
Monocyte function in children with neutropenia and chronic infections. Blood (1972) 1.98
Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. J Infect Dis (1988) 1.95
Improvement of leukocyte bactericidal activity in chronic granulomatous disease. Blood (1970) 1.90
Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the Women and Infants Transmission Study (WITS). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.88
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res (1989) 1.86
Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest (1972) 1.85
Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group. J Pediatr (1996) 1.79
Chronic granulomatous disease: correlation between pathogenesis and clinical findings. Pediatrics (1971) 1.76
Oxidant injury of caucasian glucose-6-phosphate dehydrogenase-deficient red blood cells by phagocytosing leukocytes during infection. J Clin Invest (1971) 1.72
Benign and malignant teratomas in children: analysis of 85 patients. Surgery (1976) 1.71
Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance. Blood (1983) 1.64
Cytoplasmic viscosity near the cell plasma membrane: measurement by evanescent field frequency-domain microfluorimetry. Biophys J (1993) 1.62
Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med (1979) 1.61
Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med (1978) 1.60
Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness. Blood (1981) 1.57
Protection against experimental necrotizing enterocolitis by maternal milk. I. Role of milk leukocytes. Pediatr Res (1977) 1.55
The influence of membrane skeleton on red cell deformability, membrane material properties, and shape. Semin Hematol (1983) 1.54
The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Leuk Res (1994) 1.54
Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate. N Engl J Med (1976) 1.52
Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet (1986) 1.51
Stages in the incorporation of fatty acids into red blood cells. J Clin Invest (1968) 1.49
A technique to detect reduced mechanical stability of red cell membranes: relevance to elliptocytic disorders. Blood (1982) 1.49
Monovalent cation composition and ATP and lipid content of irreversibly sickled cells. Blood (1978) 1.45
A rhesus monkey model for continuous infusion of drugs into cerebrospinal fluid. Lab Anim Sci (1990) 1.44
Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid. J Pharmacol Exp Ther (1988) 1.43
Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group. J Pediatr (1996) 1.41
Association between paracetamol and pyroglutamic aciduria. Clin Chem (1990) 1.41
Metabolic and bactericidal activities of human eosinophils. Br J Haematol (1971) 1.41
Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. Blood (1976) 1.40
Molecular and functional changes in spectrin from patients with hereditary pyropoikilocytosis. J Clin Invest (1983) 1.39
The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. J Exp Med (1987) 1.38
Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med (1983) 1.38
The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am J Med (1981) 1.38
Erythrocyte membrane rigidity induced by glycophorin A-ligand interaction. Evidence for a ligand-induced association between glycophorin A and skeletal proteins. J Clin Invest (1985) 1.38
Congenital hemolytic anemia with high-sodium, low-potassium red cells. Studies of three generations of a family with a new variant. N Engl J Med (1969) 1.37
Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med (1980) 1.36
Congenital hemolytic anemia with high sodium, low potassium red cells. I. Studies of membrane permeability. N Engl J Med (1968) 1.36
Deformability of oxygenated irreversibly sickled cells. J Clin Invest (1980) 1.36
L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res (1981) 1.34
Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol (1987) 1.34
The pharmacokinetics of zidovudine administered by continuous infusion in children. Ann Intern Med (1989) 1.33
Marked reduction of spectrinin hereditary spherocytosis in the common house mouse. Blood (1978) 1.31
Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant women. HIV Clin Trials (2001) 1.30
Effects of a chemotactic factor, N-formylmethionyl peptide, on adherence, superoxide anion generation, phagocytosis, and microtubule assembly of human polymorphonuclear leukocytes. J Lab Clin Med (1979) 1.30
Pregnancy outcome following cancer chemotherapy. Am J Med (1980) 1.30
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol (1996) 1.27
Remodeling of granulocyte membrane fatty acids during phagocytosis. J Clin Invest (1974) 1.27
Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group. Pediatrics (2000) 1.27
Erythrocyte membrane lipid reorganization during the sickling process. Br J Haematol (1979) 1.27
DNA linkage analysis of X chromosome-linked chronic granulomatous disease. Proc Natl Acad Sci U S A (1986) 1.27
The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. Drug Metab Dispos (1988) 1.26
Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease. J Reticuloendothel Soc (1972) 1.25
Inhibition of polymorphonuclear leukocyte adherence by prostacyclin. J Lab Clin Med (1980) 1.24
K-1 antigen of Escherichia coli: epidemiology and serum sensitivity of pathogenic strains. Infect Immun (1978) 1.23
Calculation of resonance energy transfer in crowded biological membranes. Biophys J (1995) 1.23
An outbreak of pneumocystis pneumonia in children with acute lymphocytic leukemia. Am J Dis Child (1978) 1.22
In vitro inhibition of granulopoiesis by 4-amino-4'-hydroxylaminodiphenyl sulfone. Br J Haematol (1980) 1.21
Reconstitution of spectrin-deficient, spherocytic mouse erythrocyte membranes. J Clin Invest (1979) 1.21
Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.20
Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood (1982) 1.20
Platelet-derived growth factor promotes human peripheral monocyte activation. Blood (1985) 1.19
Correlation between low natural killing of fibroblasts infected with herpes simplex virus type 1 and susceptibility to herpesvirus infections. J Infect Dis (1983) 1.19
Lipid membrane peroxidation in beta-thalassemia major. Blood (1976) 1.18
Lactoferrin deficiency associated with altered granulocyte function. N Engl J Med (1982) 1.17
Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J Immunol (1981) 1.16